It’s not cheap if it is going to be around $59 as the article states that it would be priced around a competitive product that is given by injection. BD
Below is a little information from the website:
ZECUITY is not for people with risk factors for heart disease unless a heart exam is done and shows no problem. 
You have a higher risk for heart disease if you:
have high blood pressure
have high cholesterol levels
smoke
are overweight
have diabetes
have a family history of heart disease
are a female who has gone through menopause
are a male over age 40
ZECUITY is not for people with risk factors for heart disease unless a heart exam is done and shows no problem. You have a higher risk for heart disease if you:
have high blood pressure
have high cholesterol levels
smoke
are overweight
have diabetes
have a family history of heart disease
are a female who has gone through menopause
are a male over age 40
NuPathe Inc. (PATH), a maker of neurological and psychiatric
medicines, won U.S. approval to sell the first skin patch to treat migraines.
The Food and Drug Administration cleared the treatment, called Zecuity, which delivers sumatriptan, the most-prescribed migraine headache medication, through a mild electrical current, Conshohocken, Pennsylvania-based NuPathe said yesterday in a statement.
Anido declined to say how much the patch would cost, though he indicated it would be comparable to the $95 that a similar medication costs as an injection.
http://www.bloomberg.com/news/2013-01-17/nupathe-wins-u-s-fda-approval-for-migraine-skin-patch.html
No comments:
Post a Comment